Literature DB >> 26697481

Metastatic colorectal cancer in a cirrhotic liver with synchronous hepatocellular carcinoma.

Michael Karass1, Emily Grossniklaus1, Talal Seoud1, Ralph Kamel1, Oluwadamilola Teniola1, Gabriela Oprea1, Daniel A Goldstein1, Sanjay Jain1.   

Abstract

We are reporting a case of a patient with a previous history of colorectal cancer (CRC) and cirrhosis, who developed concurrent liver lesions consistent with hepatocellular carcinoma (HCC); a case which is unique due to the low incidence of multiple cancers, particularly HCC in the setting of previous advanced colorectal carcinoma along, in a cirrhotic liver. We will review the known literature on multiple cancer rates found in patients with known colorectal carcinoma. We will then outline this particular patient's presentation, followed by a discussion as to why the particular concurrent development of HCC in the setting of previous CRC is of note.

Entities:  

Keywords:  Colorectal cancer (CRC); cancer; cirrhosis; hepatocellular carcinoma (HCC); metastases; metastatic; oncology

Year:  2015        PMID: 26697481      PMCID: PMC4669328          DOI: 10.3978/j.issn.2305-5839.2015.11.28

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  8 in total

1.  Multicentre study of liver metastases from colorectal cancer in pathological livers.

Authors:  Jose M Ramia; Rafael López-Andujar; Jaume Torras; Laia Falgueras; Jose Antonio Gonzalez; Belinda Sanchez; Joan Figueras
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

Review 2.  Immunotherapeutic approaches to hepatocellular carcinoma treatment.

Authors:  Alexander G Miamen; Haidong Dong; Lewis R Roberts
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

3.  Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer.

Authors:  Masashi Ueno; Tetsuichiro Muto; Masatoshi Oya; Hirotoshi Ota; Kaoru Azekura; Toshiharu Yamaguchi
Journal:  Int J Clin Oncol       Date:  2003-06       Impact factor: 3.402

Review 4.  Targeted proteomics for biomarker discovery and validation of hepatocellular carcinoma in hepatitis C infected patients.

Authors:  Gul M Mustafa; Denner Larry; John R Petersen; Cornelis J Elferink
Journal:  World J Hepatol       Date:  2015-06-08

5.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

8.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

Authors:  V Mazzaferro; E Regalia; R Doci; S Andreola; A Pulvirenti; F Bozzetti; F Montalto; M Ammatuna; A Morabito; L Gennari
Journal:  N Engl J Med       Date:  1996-03-14       Impact factor: 176.079

  8 in total
  1 in total

1.  Enhanced colorectal cancer metastases in the alcohol-injured liver.

Authors:  Ashley M Mohr; John J Gould; Jacy L Kubik; Geoffrey A Talmon; Carol A Casey; Peter Thomas; Dean J Tuma; Benita L McVicker
Journal:  Clin Exp Metastasis       Date:  2017-02-06       Impact factor: 5.150

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.